Regulatory

Weekly Digest – April 2025 Weekly Digest – April 2025 02 Apr 2025: Mabwell announces NMPA approval to initiate clinical trial of novel B7-H3-targeting ADC for advanced solid tumors in combination with PD-1 inhibitor Mabwell’s novel B7-H3-targeting ADC, 7MW3711, has […]

by Sandhya Ramalingam

Continue Reading

Weekly Digest – April 2025 Weekly Digest – April 2025 31 Mar 2025: SPARC announces submission of IND application for SBO-154 to USFDA SPARC submitted an Investigational New Drug (IND) application to the US FDA on March 31, 2025, for […]

by Sandhya Ramalingam

Continue Reading

Weekly Digest – April 2025 Weekly Digest – April 2025 01 Apr 2025: OBI has submitted the IND application of a Phase 1/2 human clinical trial for OBI-902 TROP2 ADC to the US FDA OBI Pharma submitted an Investigational New […]

by Sandhya Ramalingam

Continue Reading